Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Can Cost Mining Optimize Colorectal Cancer Care Pathways for Better Outcomes?
Management & Administration Can Cost Mining Optimize Colorectal Cancer Care Pathways for Better Outcomes?

Recent advancements in healthcare have witnessed significant strides, particularly in the realm of oncology, which has led to the development of innovative technologies and therapies that promise better patient outcomes. However, alongside these improvements, the complexity and specialization of

CFPB Highlights Key Consumer Protections and Regulatory Actions
Management & Administration CFPB Highlights Key Consumer Protections and Regulatory Actions

The November 2024 CFPB Bites of the Month article titled "CFPB Take Me Home, Country Roads" presents an in-depth synthesis of various Consumer Financial Protection Bureau (CFPB) activities, findings, and actions from the previous months covered during the November 2024 webinar. This

Telemedicine in Malaysia: Balancing Convenience with Potential Misuse
Tech & Innovation Telemedicine in Malaysia: Balancing Convenience with Potential Misuse

In recent years, Malaysia has witnessed a significant surge in the use of telemedicine apps, allowing patients to conveniently obtain medical consultations and medical certificates (MCs) from the comfort of their homes. These apps, including popular platforms like Doctor Anywhere, ManaDr, and

Dr. Curt Samlaska's Innovations in Dermatology and Telemedicine Leadership
Tech & Innovation Dr. Curt Samlaska's Innovations in Dermatology and Telemedicine Leadership

Dr. Curt Samlaska's legacy in both dermatology and telemedicine has been marked by a profound commitment to advancing medical practices and accessibility. His remarkable career began with an education at the University of Minnesota, where he earned his medical degree. This foundational journey

Advocate Health Care's $1B Investment Revitalizes Chicago's South Side
Care Providers Advocate Health Care's $1B Investment Revitalizes Chicago's South Side

Advocate Health Care has announced a transformative $1 billion investment aimed at expanding healthcare access and promoting wellness on Chicago's South Side. This ambitious, community-focused initiative is intended to bridge the stark 30-year life expectancy gap between residents of the South

Is the FDA's Early Alert on Ivenix Infusion Pumps Enough to Ensure Safety?
Management & Administration Is the FDA's Early Alert on Ivenix Infusion Pumps Enough to Ensure Safety?

The recent announcement by the FDA concerning the potential high-risk issue with Fresenius Kabi’s Ivenix large-volume infusion pumps (LVP) has raised important questions regarding the adequacy of safety measures in medical device usage. The initial alert followed a company communication from F

How Is IoT Transforming Communication Between Patients and Providers?
Tech & Innovation How Is IoT Transforming Communication Between Patients and Providers?

In an age where technology continues to evolve at a rapid pace, the Internet of Things (IoT) is making a significant impact on the healthcare industry by enhancing patient-provider communication through real-time data sharing and personalized services. This technological revolution is especially

Are Children Getting Full Medicaid Pediatric Benefits and Care?
Management & Administration Are Children Getting Full Medicaid Pediatric Benefits and Care?

Medicaid’s pediatric benefit package, known as Early and Periodic Screening, Diagnostic, and Treatment (EPSDT), is designed to provide comprehensive health coverage to over 30 million children in the United States. This program is particularly crucial for low-income families, children of color, and

Telemedicine's Role in Fighting Opioid Crisis Must Continue
Tech & Innovation Telemedicine's Role in Fighting Opioid Crisis Must Continue

The COVID-19 pandemic brought about unprecedented changes in many aspects of healthcare, including the treatment of opioid use disorder. One of the most significant changes was the relaxation of regulations around the prescription of buprenorphine, a medication approved by the FDA for treating

Health Insurers' Executive Security: Balancing Costs and Necessity
Management & Administration Health Insurers' Executive Security: Balancing Costs and Necessity

When considering the financial landscape of health insurance companies, one often contemplates policyholder benefits, premiums, and claims rather than the intricate details of executive security spending. This lesser-known aspect of corporate operations unveils a surprisingly broad spectrum of

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later